The Value of Chart Reviews

Jan 23, 2014
As recently published in Pharmaphorum, chart reviews capture real-world patient-level clinical, healthcare and safety data.

As we recently discussed in an article in Pharmaphorum, retrospective chart review studies can result in tailored patient-level datasets. They also can be designed and executed in less time than various observational study designs.

Though this methodology is associated with some important limitations, retrospective chart reviews are free from the Hawthorne effect and response bias. They can facilitate the collection of data that reflect true physician and patient characteristics, patterns of care, drug utilization and clinical outcomes. Not surprisingly, chart review studies are employed most often to identify areas of unmet clinical need, quantify patterns and costs of care, and to evaluate the frequency of off-label drug use and other inappropriate use.

Click to download the full article.

Author Bio

Lab Staff
comments powered by Disqus